Get notified when DX files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsDynex Capital doubles authorized shares to 720M following shareholder approval
Filed May 22, 2026 · Period ending May 21, 2026 · ~1 min read
Key Changes
-
high
Shareholders approved doubling authorized common stock from 360 million to 720 million shares, effective May 22, 2026. This expansion gives management significantly more capacity to issue new equity for capital raises, acquisitions, or compensation, creating potential for future shareholder dilution.
Item 5.03: Charter Amendment verify on EDGAR → -
low
Board approved standardized indemnification agreements for all directors and executive officers, providing maximum legal protection under Virginia law and ensuring continued D&O insurance coverage. This is a common governance practice to attract and retain qualified leadership.
Item 1.01: Indemnification view on EDGAR → -
low
Six directors re-elected at 2026 Annual Meeting with strong shareholder support (over 76M votes each): Byron Boston, Marie Chandoha, Julia Coronado, Alexander Crawford, Andrew Gray, and Smriti Popenoe.
Item 5.07: Annual Meeting verify on EDGAR →
1 more material change behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (SNOA 10-K) is open in full — no account needed.
Partner
Trade DX commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · May 26, 2026 10:35 AM